Skip to main content
Equibles

GOLDMAN SACHS GROUP INC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 886982 NEW YORK, NY
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$19,210,535
+$11,813,154 QoQ
Shares Held
575,338
+62.9% QoQ
Ownership
0.584%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Jun 30, 2026
CallValue
$2,003,400
CallShares
60,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. RARE ranks #117 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,481,761 $1,232,765,138
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,163,191 $725,296,113
3 ROIV
Roivant Sciences Ltd.
 18,556,458 $656,713,046
4 TECH
BIO-TECHNE Corp
 7,343,324 $518,805,838
5 RVMD
Revolution Medicines, Inc.
 2,133,101 $399,487,154
6 MRNA
Moderna, Inc.
 4,671,950 $327,176,656
7 TNGX
Tango Therapeutics, Inc.
 9,980,620 $311,994,180
8 INCY
Incyte Corp
 2,305,782 $261,383,446

All Filings in RARE

Export CSV
40 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,210,535 575,338
2026-06-30 $2,003,400 60,000
2026-03-31 $7,397,381 353,097
2026-03-31 $366,625 17,500
2025-12-31 $230,000 10,000
2025-12-31 $1,495,000 65,000
2025-12-31 $9,208,234 400,358
2025-09-30 $1,203,200 40,000
2025-09-30 $14,346,294 476,938
2025-06-30 $723,564 19,900
2025-06-30 $15,489,140 425,994
2025-03-31 $17,390,539 480,269
2024-12-31 $23,292,896 553,670
2024-09-30 $28,136,629 506,510
2024-06-30 $25,873,024 629,514
2024-03-31 $17,000,855 364,122
2023-12-31 $7,414,586 155,052
2023-09-30 $13,949,951 391,303
2023-06-30 $24,759,261 536,728
2023-03-31 $17,844,779 445,007
2022-12-31 $51,626,352 1,114,318
2022-09-30 $41,873,294 1,011,188
2022-06-30 $51,312,074 860,075
2022-03-31 $55,717,040 767,241
2021-12-31 $61,022,262 725,678
2021-09-30 $45,654,898 506,208
2021-06-30 $61,276,677 642,650
2021-03-31 $86,319,656 758,121
2021-03-31 $3,415,800 30,000
2021-03-31 $6,934,074 60,900
2020-12-31 $8,430,387 60,900
2020-12-31 $4,152,900 30,000
2020-12-31 $120,825,579 872,828
2020-09-30 $35,957,796 437,496
2020-06-30 $34,885,337 445,990
2020-06-30 $2,346,600 30,000
2020-06-30 $2,346,600 30,000
2020-03-31 $2,665,800 60,000
2020-03-31 $4,420,785 99,500
2020-03-31 $20,238,841 455,522